Antoine Roquilly

Has grant

Prof

University Hospital

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Antoine Roquilly is a faculty member at University Hospital in France. His research primarily focuses on the progression of kidney fibrosis, airway microbiome in respiratory failure, and innovative approaches to managing hospital-acquired pneumonia in critically ill patients. Recent publications also delve into the role of intestinal metabolites in immune responses and the effects of treatments such as interferon gamma-1b and ruxolitinib in clinical settings.

Recent Grants

Grant: Close

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Open Date: 2020-01-01

Close Date: 2024-12-31

Grant: Close

Efficiency of Interleukin 12 for the treatment and the prevention of hospital-acquired pneumonia – IL12 for HAP

Open Date: 2018-07-20

Close Date: 2020-07-19

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Christos Chadjichristos

Associate Professor

INSERM

FRANCE

View details

Benjamin Gaborit

Université de Nantes

FRANCE

View details

Antoine ASQUIER-KHATI

University Hospital

FRANCE

View details

Benjamin Glenn Chousterman

Associate-Professor (MCU-PH)

Université Paris-Saclay

FRANCE

View details

Benoit Salomon

INSERM

FRANCE

View details

Susan V. Lynch

University of California

UNITED STATES

View details

Jose A. Villadangos

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antoine Roquilly

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Progression of Kidney Fibrosis after Sepsis

High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial

Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia

Intestinal microbe-derived metabolites instruct macrophages in the lungs

Monocyte Signature Associated with Herpes Simplex Virus Reactivation and Neurological Recovery After Brain Injury.

Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study.

Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial.

Spatiotemporal Adaptations of Macrophage and Dendritic Cell Development and Function.

New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness-Related Immunosuppression.

Empiric antimicrobial therapy for early-onset pneumonia in severe trauma patients.

Circulating Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Contribute to Sepsis-Induced Immunosuppression in Patients During Septic Shock.

Collaborators (7)

Christos Chadjichristos

Benjamin Gaborit

Antoine ASQUIER-KHATI

Benjamin Glenn Chousterman

Benoit Salomon

Susan V. Lynch

Jose A. Villadangos

Make your next move.